$WST
WEST PHARMACEUTICAL SERVICES INC

2021 Q4 Form 10-Q Financial Statement

#000010577021000083 Filed on October 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $730.8M $706.5M $548.0M
YoY Change 25.96% 28.92% 20.15%
Cost Of Revenue $428.3M $418.3M $353.4M
YoY Change 16.04% 18.36% 14.63%
Gross Profit $302.5M $288.2M $194.6M
YoY Change 43.3% 48.1% 31.66%
Gross Profit Margin 41.39% 40.79% 35.51%
Selling, General & Admin $97.10M $91.90M $76.20M
YoY Change 27.26% 20.6% 17.59%
% of Gross Profit 32.1% 31.89% 39.16%
Research & Development $13.70M $13.10M $12.50M
YoY Change 6.2% 4.8% 34.41%
% of Gross Profit 4.53% 4.55% 6.42%
Depreciation & Amortization $34.40M $30.00M $28.40M
YoY Change 20.7% 5.63% 12.25%
% of Gross Profit 11.37% 10.41% 14.59%
Operating Expenses $114.2M $105.0M $88.70M
YoY Change 24.95% 18.38% 19.7%
Operating Profit $188.3M $181.4M $99.20M
YoY Change 57.31% 82.86% 47.4%
Interest Expense -$3.400M $1.800M $2.100M
YoY Change -30.61% -14.29% 0.0%
% of Operating Profit -1.81% 0.99% 2.12%
Other Income/Expense, Net $1.400M -$300.0K -$1.500M
YoY Change 55.56% -80.0% 15.38%
Pretax Income $181.9M $181.1M $97.70M
YoY Change 58.04% 85.36% 50.54%
Income Tax $34.20M $12.00M $21.10M
% Of Pretax Income 18.8% 6.63% 21.6%
Net Earnings $147.7M $175.6M $82.30M
YoY Change 50.1% 113.37% 46.18%
Net Earnings / Revenue 20.21% 24.85% 15.02%
Basic Earnings Per Share $2.37 $1.11
Diluted Earnings Per Share $1.898M $2.31 $1.09
COMMON SHARES
Basic Shares Outstanding 74.08M shares 74.10M shares 73.90M shares
Diluted Shares Outstanding 76.00M shares 75.80M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $762.6M $688.0M $519.4M
YoY Change 23.9% 32.46% 31.16%
Cash & Equivalents $762.6M $688.0M $519.4M
Short-Term Investments
Other Short-Term Assets $112.0M $80.10M $51.00M
YoY Change 117.05% 57.06% -17.21%
Inventory $378.4M $353.8M $294.9M
Prepaid Expenses
Receivables $489.0M $476.4M $373.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.742B $1.598B $1.238B
YoY Change 26.81% 29.07% 23.32%
LONG-TERM ASSETS
Property, Plant & Equipment $1.058B $1.007B $883.4M
YoY Change 12.12% 13.93% 8.78%
Goodwill $109.9M $108.9M $109.3M
YoY Change -1.08% -0.37% 2.53%
Intangibles $23.00M $26.10M $30.60M
YoY Change -24.59% -14.71% 6.62%
Long-Term Investments $201.2M $207.1M $194.2M
YoY Change -0.35% 6.64% 131.19%
Other Assets $39.20M $31.60M $21.80M
YoY Change 67.52% 44.95% 9.0%
Total Long-Term Assets $1.572B $1.544B $1.345B
YoY Change 10.68% 14.86% 14.92%
TOTAL ASSETS
Total Short-Term Assets $1.742B $1.598B $1.238B
Total Long-Term Assets $1.572B $1.544B $1.345B
Total Assets $3.314B $3.143B $2.583B
YoY Change 18.61% 21.67% 18.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $232.2M $207.7M $180.3M
YoY Change 8.96% 15.2% 24.09%
Accrued Expenses $128.0M $124.5M $108.2M
YoY Change 8.11% 15.06% 27.9%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $44.20M $44.20M $2.300M
YoY Change 1821.74% 1821.74%
Total Short-Term Liabilities $594.1M $558.6M $447.7M
YoY Change 18.02% 24.77% 33.64%
LONG-TERM LIABILITIES
Long-Term Debt $208.8M $209.9M $253.4M
YoY Change -17.44% -17.17% 29.88%
Other Long-Term Liabilities $38.20M $27.80M $46.80M
YoY Change 20.13% -40.6% 31.09%
Total Long-Term Liabilities $247.0M $237.7M $300.2M
YoY Change -13.24% -20.82% 30.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $594.1M $558.6M $447.7M
Total Long-Term Liabilities $247.0M $237.7M $300.2M
Total Liabilities $978.4M $940.3M $863.9M
YoY Change 4.16% 8.84% 25.86%
SHAREHOLDERS EQUITY
Retained Earnings $2.457B $2.336B $1.773B
YoY Change 33.03% 31.71% 18.44%
Common Stock $18.80M $18.80M $18.80M
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $229.5M $247.8M $182.0M
YoY Change 36.85% 36.15% 43.76%
Treasury Stock Shares 1.100M shares 1.200M shares 1.400M shares
Shareholders Equity $2.335B $2.202B $1.719B
YoY Change
Total Liabilities & Shareholders Equity $3.314B $3.143B $2.583B
YoY Change 18.61% 21.67% 18.8%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $147.7M $175.6M $82.30M
YoY Change 50.1% 113.37% 46.18%
Depreciation, Depletion And Amortization $34.40M $30.00M $28.40M
YoY Change 20.7% 5.63% 12.25%
Cash From Operating Activities $160.8M $190.1M $118.6M
YoY Change 8.14% 60.29% 9.71%
INVESTING ACTIVITIES
Capital Expenditures -$76.50M -$65.30M $47.50M
YoY Change -241.93% -237.47% 49.84%
Acquisitions
YoY Change
Other Investing Activities -$900.0K $0.00 -$1.600M
YoY Change -75.68% -100.0% -1700.0%
Cash From Investing Activities -$77.40M -$65.30M -$49.10M
YoY Change 34.38% 32.99% 55.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.200M -5.800M -7.200M
YoY Change -28.74% -19.44% 1700.0%
NET CHANGE
Cash From Operating Activities 160.8M 190.1M 118.6M
Cash From Investing Activities -77.40M -65.30M -49.10M
Cash From Financing Activities -6.200M -5.800M -7.200M
Net Change In Cash 77.20M 119.0M 62.30M
YoY Change -6.31% 91.01% -18.13%
FREE CASH FLOW
Cash From Operating Activities $160.8M $190.1M $118.6M
Capital Expenditures -$76.50M -$65.30M $47.50M
Free Cash Flow $237.3M $255.4M $71.10M
YoY Change 150.32% 259.21% -6.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000105770
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2019 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-8036
dei Entity Registrant Name
EntityRegistrantName
WEST PHARMACEUTICAL SERVICES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-1210010
dei Entity Address Address Line1
EntityAddressAddressLine1
530 Herman O. West Drive
CY2020Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
500000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
254100000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
255200000 USD
dei Entity Address City Or Town
EntityAddressCityOrTown
Exton
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19341-0645
dei City Area Code
CityAreaCode
610
dei Local Phone Number
LocalPhoneNumber
594-2900
dei Security12b Title
Security12bTitle
Common Stock, par value $0.25 per share
dei Trading Symbol
TradingSymbol
WST
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
74079715 shares
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
706500000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
548000000.0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2100800000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1566700000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
418300000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
353400000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1225600000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1010000000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
288200000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
194600000 USD
us-gaap Gross Profit
GrossProfit
875200000 USD
us-gaap Gross Profit
GrossProfit
556700000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13100000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12500000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39100000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34000000.0 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
91900000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
76200000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
264800000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
225700000 USD
CY2021Q3 wst Other Income Expense
OtherIncomeExpense
-1800000 USD
CY2020Q3 wst Other Income Expense
OtherIncomeExpense
-6700000 USD
wst Other Income Expense
OtherIncomeExpense
-3000000.0 USD
wst Other Income Expense
OtherIncomeExpense
-6200000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
181400000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
99200000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
568300000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
290800000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
1800000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
2100000 USD
us-gaap Interest Expense
InterestExpense
5600000 USD
us-gaap Interest Expense
InterestExpense
6100000 USD
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
400000 USD
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
200000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
700000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
1200000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1100000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
400000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3600000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
300000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
181100000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
97700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
567000000.0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
286200000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000000.0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000000.0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52100000 USD
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6500000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5700000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
20100000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
13700000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
175600000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
82300000 USD
us-gaap Net Income Loss
NetIncomeLoss
514100000 USD
us-gaap Net Income Loss
NetIncomeLoss
247800000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.37
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.95
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.35
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.31
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.78
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.28
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74100000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76000000.0 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75600000 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
175600000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
82300000 USD
us-gaap Net Income Loss
NetIncomeLoss
514100000 USD
us-gaap Net Income Loss
NetIncomeLoss
247800000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-24200000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
29400000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-46900000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4900000 USD
CY2021Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
200000 USD
CY2020Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-100000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
400000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-1200000 USD
CY2021Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-400000 USD
CY2020Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
200000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-1100000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
4000000.0 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
-400000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
-200000 USD
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
-400000 USD
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease Adjustments Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsTax
-400000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
1300000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
-900000 USD
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
700000 USD
us-gaap Other Comprehensive Income Loss Derivative Excluded Component Increase Decrease After Adjustments And Tax
OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax
-1000000.0 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22500000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
28300000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-45100000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9900000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
153100000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
110600000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
469000000.0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
237900000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
688000000.0 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
615500000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
476400000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
385300000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
353800000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
321300000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
80100000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
51600000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1598300000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1373700000 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2146100000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2035500000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1139600000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1092300000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1006500000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
943200000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58500000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68300000 USD
CY2021Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
215700000 USD
CY2020Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
214700000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
108900000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
111100000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
26100000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30500000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
80000000.0 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16000000.0 USD
CY2021Q3 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
17000000.0 USD
CY2020Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
12900000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
31600000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23400000 USD
CY2021Q3 us-gaap Assets
Assets
3142600000 USD
CY2020Q4 us-gaap Assets
Assets
2793800000 USD
CY2021Q3 us-gaap Debt Current
DebtCurrent
44200000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
2300000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
207700000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
213100000 USD
CY2021Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2400000 USD
CY2020Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2300000 USD
CY2021Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
114000000.0 USD
CY2020Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
106000000.0 USD
CY2021Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
39500000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
26000000.0 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8100000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10100000 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
142700000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
503400000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
558600000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
143600000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
209900000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
252900000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11600000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10400000 USD
CY2021Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
52100000 USD
CY2020Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
57500000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53400000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
60400000 USD
CY2021Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
26900000 USD
CY2020Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
22900000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27800000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
31800000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
940300000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
939300000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75300000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75300000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74100000 shares
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2793800000 USD
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74000000 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
18800000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
18800000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
251200000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
267300000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2335800000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1846700000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-155700000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-110600000 USD
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1200000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1300000 shares
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
247800000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
167700000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
2202300000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1854500000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3142600000 USD
us-gaap Net Income Loss
NetIncomeLoss
514100000 USD
us-gaap Net Income Loss
NetIncomeLoss
247800000 USD
us-gaap Depreciation
Depreciation
84600000 USD
us-gaap Depreciation
Depreciation
77300000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
3300000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
3300000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
27500000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
27600000 USD
wst Pension Settlement Charge
PensionSettlementCharge
700000 USD
wst Pension Settlement Charge
PensionSettlementCharge
3400000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
1000000.0 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
700000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
17500000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
9500000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
188500000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
25400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
423200000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
323800000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
176900000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
116700000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3800000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1200000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1400000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-175700000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121900000 USD
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1100000 USD
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1700000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
37800000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
35500000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23100000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
22000000.0 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
5700000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4600000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
137100000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
115500000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14700000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2300000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-161900000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-128400000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-13100000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
6800000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
72500000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
80300000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
615500000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
439100000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
688000000.0 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
519400000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
10900000 USD
CY2021Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
12800000 USD
wst Contract With Customer Asset Increase Decrease
ContractWithCustomerAssetIncreaseDecrease
1900000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
57100000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
38100000 USD
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
19000000.0 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
30000000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
175600000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
82300000 USD
us-gaap Net Income Loss
NetIncomeLoss
514100000 USD
us-gaap Net Income Loss
NetIncomeLoss
247800000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74100000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1900000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1900000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1800000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1700000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76000000.0 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75600000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2020Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
631000 shares
CY2021Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
479000 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
137100000 USD
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
286.23
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
140400000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
133500000 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
71100000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
54900000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
142300000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
132900000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
353800000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
321300000 USD
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3300000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3100000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
9500000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
9300000 USD
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
400000 USD
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
300000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
900000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
600000 USD
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1100000 USD
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1200000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
3300000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
2800000 USD
CY2021Q3 us-gaap Lease Cost
LeaseCost
4800000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
4600000 USD
us-gaap Lease Cost
LeaseCost
13700000 USD
us-gaap Lease Cost
LeaseCost
12700000 USD
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
2900000 USD
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
3200000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
9200000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
9600000 USD
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8700000 USD
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
300000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
800000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4600000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y10M24D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y1M6D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0367
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0368
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3000000.0 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12400000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10300000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10400000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9300000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
9300000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8500000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6800000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6900000 USD
CY2021Q3 wst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
36200000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
37500000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
74100000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
85200000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12600000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
14700000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
61500000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
70500000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
207100000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
201900000 USD
CY2021Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
8600000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
12800000 USD
CY2021Q3 wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
34000000 USD
wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
119600000 USD
wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
97000000.0 USD
CY2020Q3 wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
36600000 USD
CY2021Q3 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
13800000 USD
CY2020Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
33600000 USD
CY2021Q3 wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
2800000 USD
wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
8800000 USD
CY2020Q3 wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
2700000 USD
wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
7700000 USD
CY2021Q3 us-gaap Due From Affiliates
DueFromAffiliates
2200000 USD
CY2020Q4 us-gaap Due From Affiliates
DueFromAffiliates
1400000 USD
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
254600000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
255700000 USD
CY2021Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
500000 USD
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
44200000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2300000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
209900000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
252900000 USD
CY2021Q3 us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
900000 USD
CY2020Q3 us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
1900000 USD
us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
2100000 USD
us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
5900000 USD
CY2021Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
14400000 USD
CY2021Q3 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
1800000 USD
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
30400000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3500000 USD
CY2021Q3 us-gaap Other Deferred Compensation Arrangements Liability Classified Noncurrent
OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
15700000 USD
CY2021Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
22000000.0 USD
CY2020Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
12800000 USD
CY2020Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
3000000.0 USD
CY2020Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
300000 USD
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
16100000 USD
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3600000 USD
CY2020Q4 us-gaap Other Deferred Compensation Arrangements Liability Classified Noncurrent
OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent
14500000 USD
CY2020Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
33400000 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3300000 USD
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-1200000 USD
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
900000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1854500000 USD
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3600000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-900000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
1000000.0 USD
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3500000 USD
CY2021Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
220300000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
209900000 USD
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
265700000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
252900000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-48800000 USD
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-3700000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-45100000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
151200000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2500000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
137100000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.17
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12500000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-29600000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1829000000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
187300000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
21800000 USD
CY2021Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.17
CY2021Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
12500000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7000000.0 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2032600000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
175600000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16600000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-22500000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
2202300000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1573200000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
74300000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12800000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
115500000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11800000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-42700000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1490200000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
91200000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20400000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4500000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1606300000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
82300000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13900000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11900000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
28300000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1718900000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2485724 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
159932 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
277.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
63.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.239
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.003
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11400000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27500000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10000000.0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27600000 USD
CY2021Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
100000 USD
CY2020Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
400000 USD
CY2021Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1600000 USD
CY2020Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1700000 USD
CY2021Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2900000 USD
CY2020Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2800000 USD
CY2021Q3 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-100000 USD
CY2020Q3 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-100000 USD
CY2021Q3 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-200000 USD
CY2020Q3 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
200000 USD
CY2021Q3 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
0 USD
CY2020Q3 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-1100000 USD
CY2021Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-1100000 USD
CY2020Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
100000 USD
CY2021Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-1100000 USD
CY2020Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
100000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
5600000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
9000000.0 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
900000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1000000.0 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
4600000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
8800000 USD
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-200000 USD
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-400000 USD
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
-300000 USD
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
0 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-700000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-3400000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-2700000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
800000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
-2700000 USD
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1000000.0 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
800000 USD
CY2021Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
400000 USD
CY2020Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
4500000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
2500000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
4500000 USD
CY2021Q3 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
200000 USD
CY2020Q3 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
900000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
600000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
7200000 USD
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
100000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
800000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
900000 USD
CY2021Q3 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-900000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
900000 USD
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-400000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2500000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4500000 USD
CY2021Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-700000 USD
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
500000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1500000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1900000 USD
CY2021Q3 wst Other Income Expense
OtherIncomeExpense
-1800000 USD
CY2020Q3 wst Other Income Expense
OtherIncomeExpense
-6700000 USD
wst Other Income Expense
OtherIncomeExpense
-3000000.0 USD
wst Other Income Expense
OtherIncomeExpense
-6200000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1800000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
2200000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21100000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.066
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000000.0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52100000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.129
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.182
CY2021Q3 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
20400000 USD
us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
20400000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
706500000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
548000000.0 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2100800000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1566700000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
181400000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
99200000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
568300000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
290800000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-300000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1500000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1300000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4600000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
181100000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
97700000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
567000000.0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
286200000 USD

Files In Submission

Name View Source Status
0000105770-21-000083-index-headers.html Edgar Link pending
0000105770-21-000083-index.html Edgar Link pending
0000105770-21-000083.txt Edgar Link pending
0000105770-21-000083-xbrl.zip Edgar Link pending
char1-1826719v3xlibortrans.htm Edgar Link pending
ex311q32021.htm Edgar Link pending
ex312q32021.htm Edgar Link pending
ex321q32021.htm Edgar Link pending
ex322q32021.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wst-20210930.htm Edgar Link pending
wst-20210930.xsd Edgar Link pending
wst-20210930_cal.xml Edgar Link unprocessable
wst-20210930_def.xml Edgar Link unprocessable
wst-20210930_htm.xml Edgar Link completed
wst-20210930_lab.xml Edgar Link unprocessable
wst-20210930_pre.xml Edgar Link unprocessable